Back to search

Sweden· SE-20161123000026

Anagrelide Sandoz 0,5 mg Kapsel, hård

A anagrelide product containing anagrelide, registered in Sweden by Sandoz A/S. The same ATC class is registered in 19 of our 19 countries.

ATC L01XX35

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedAnagrelide Sandoz 0,5 mg Kapsel, hårdATCL01XX35REGISTER NO.SE-20161123000026PACKS LISTED1CHECKEDOctober 1, 2026

Where it is registered

Anagrelide is registered in 19 of 19 countries.

Countries holding a registration under ATC L01XX35 (anagrelide), each read from that country’s own register.

  • This record: Sweden, from Swedish Medical Products Agency (Sweden)
  • 11 of them publish a price we can compare per daily dose

Anagrelide · ATC L01XX35

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of anagrelide costs, country by country.

Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Anagrelide · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • IT Italy$15.54
  • ES Spain$14.25
  • CH Switzerland$11.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Anagrelide
Manufacturer
Sandoz A/S
Country
Sweden (SE)
ATC code
L01XX35
ATC class
Anagrelide
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20161123000026

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

438 interactions on record for anagrelide.

Graded by severity as the source publishes them — 274 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Anagrelide · interactions on record

438 records

  • 274 severe
  • 156 moderate
  • 4 minor
  • 4 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Anagrelide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All anagrelide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Anagrelid +pharma, Anagrelid Aop
  • Belgium · Anagrelid Sandoz, Atremia
  • Bulgaria · Тромборедуктин
  • Cyprus · Anagrelide Aop
  • Czechia · Anagrelid Stada, Anagrelide Teva
  • Germany · Anagrelid Abz, Anagrelid Al
  • Denmark · Anagrelid Bluefish, Anagrelide "stada"
  • Spain · Anagrelida Aurovitas, Anagrelida Bluefish
  • Finland · Anagrelid Avansor, Anagrelid Orion
  • France · Anagrelide Arrow, Anagrelide Biogaran
  • United Kingdom (Northern Ireland) · Anagrelide Bluefish, Anagrelide Brown & Burk Uk
  • Greece · Anagrelide Aop, Anagrelide Teva
  • Croatia · Anagrelid, Anagrelid Stada
  • Hungary · Adride, Anagrelide Stada
  • Ireland · Anagrelide Athlone Pharmaceuticals
  • Iceland · Anagrelide Bluefish, Anagrelide Viatris
  • Italy · Anagrelide Aurobindo, Anagrelide Sandoz
  • Liechtenstein · Anagrelide Viatris, Xagrid
  • Lithuania · Anagrelide Teva, Thromboreductin
  • Luxembourg · Atremia
  • Latvia · Thromboreductin
  • Malta · Anagrelide Torrent
  • Netherlands · Anagrelide Accord, Anagrelide Cf
  • Norway · Anagrelide Bluefish, Anagrelide Viatris
  • Poland · Anagrelid Aurovitas, Anagrelide
  • Portugal · Anagrelida Aurovitas, Anagrelida Bluefish
  • Romania · Anagrelidă Accord, Grenalvon
  • Slovenia · Anagrelid Sandoz, Anagrelid Teva
  • Slovakia · Anagrelide Glenmark, Anagrelide Vipharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f707a8c8-6c1c-46cb-994c-1b5c14d896ad
GET /v1/drugs/f707a8c8-6c1c-46cb-994c-1b5c14d896ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20161123000026",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20161123000026",
  "product_doc_link": "https://docetp.mpa.se/LMF/Anagrelide%20Sandoz%20capsule%2C%20hard%20SmPC_09001bee807a2ce8.pdf"
}

See everything about anagrelide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.